The DOI matches its Crossref record; 372 of the 375 references it cites were found in a registry or an index.
Recent progress in functionalized and targeted polymersomes and chimeric polymeric nanotheranostic platforms for cancer therapy
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Research and clinical trials in this domain have surged, indicating the potential to minimize side effects and target minute cancer cell deposits throughout the body [113].”
From Radiopharmaceuticals: navigating the frontier of precision medicine and therapeutic innovation (2024) · cites this paper as [113]
Citations
Cites
2 retracted
Zhang, W., Taheri-Ledari, R., Ganjali, F., Afruzi, F. H., Hajizadeh, Z., Saeidirad, M., Qazi, F. S., Kashtiaray, A., Sehat, S. S., Hamblin, M. R., et al. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09577 · Cited by 79
RetractedRoy, E., Patra, S., Madhuri, R., & Sharma, P. K. (2017) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b00089 · Cited by 16
RetractedApplications of Carbon Nanotubes in Drug Delivery
Kaur, J., Gill, G. S., & Jeet, K. (2005) · Elsevier eBooks · doi:10.1016/b978-0-12-814031-4.00005-2 · Cited by 2,023
Mechanisms of Multidrug Resistance in Cancer Chemotherapy
Bukowski, K., Kciuk, M., & Kontek, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093233 · Cited by 1,853
Schirrmacher, V. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4661 · Cited by 1,342
Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer?
Nakamura, Y., Mochida, A., Choyke, P. L., & Kobayashi, H. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00437 · Cited by 1,144
Liposomes and polymersomes: a comparative review towards cell mimicking
Rideau, E., Dimova, R., Schwille, P., Wurm, F. R., & Landfester, K. (2018) · Chemical Society Reviews · doi:10.1039/c8cs00162f · Cited by 1,144
Imaging biomarker roadmap for cancer studies
O'Connor, J. P. B., Aboagye, E. O., Adams, J. E., Aerts, H. J. W. L., Barrington, S. F., Beer, A. J., Boellaard, R., Bohndiek, S. E., Brady, M., Brown, G., et al. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.162 · Cited by 1,091
Engineering Macrophages for Cancer Immunotherapy and Drug Delivery
Xia, Y., Rao, L., Yao, H., Wang, Z., Ning, P., & Chen, X. (2020) · Advanced Materials · doi:10.1002/adma.202002054 · Cited by 949
Immune checkpoint inhibitors of PD-L1 as cancer therapeutics
Akinleye, A., & Rasool, Z. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0779-5 · Cited by 760
Research works printed but not linked: 5
- Siegel, 2023, Cancer statistics, 2023, CA: Cancer J Clin, 73, 17
- Ramachandruni, 2020, 100 Flash NanoPrecipitation (FNP)—Principles and applications in medical imaging and drug delivery, Material Matters™, 100
- Simón-Gracia, 2018, Application of polymersomes engineered to target p32 protein for detection of small breast tumors in mice, bioRxiv, 187716
- Wu, 2017, Magnetic nanoparticles in cancer diagnosis, drug delivery and treatment, Mol Clin Oncol, 7, 738
- Simón-Gracia, 2018, Application of polymersomes engineered to target p32 protein for detection of small breast tumors in mice, Oncotarget, 9, 18682, 10.18632/oncotarget.24588 · DOI
Cited by
Sorted by citations
Radiopharmaceuticals: navigating the frontier of precision medicine and therapeutic innovation
Dhoundiyal, S., Srivastava, S., Kumar, S., Singh, G., Ashique, S., Pal, R., Mishra, N., & Taghizadeh-Hesary, F. (2024) · European Journal of Medical Research · doi:10.1186/s40001-023-01627-0 · Cited by 144
“Research and clinical trials in this domain have surged, indicating the potential to minimize side effects and target minute cancer cell deposits throughout the body [113].”
BackgroundRecent advances in gene delivery nanoplatforms based on spherical nucleic acids
Valatabar, N., Oroojalian, F., Kazemzadeh, M., Mokhtarzadeh, A. A., Safaralizadeh, R., & Sahebkar, A. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02648-5 · Cited by 34
Self-citationOroojalian, F., Azizollahi, F., Kesharwani, P., & Sahebkar, A. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.07.048 · Cited by 25
Self-citationPolymersome-based nanomotors: preparation, motion control, and biomedical applications
Song, S., Han, H., Wang, J., Pu, Y., Shao, J., Xie, J., Che, H., van Hest, J. C. M., & Cao, S. (2025) · Chemical Science · doi:10.1039/d4sc08283d · Cited by 24
Saadh, M. J., Mustafa, M. A., Kumar, S., Gupta, P., Pramanik, A., Rizaev, J. A., Shareef, H. K., Alubiady, M. H. S., Al‐Abdeen, S. H. Z., Shakier, H. G., et al. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03104-9 · Cited by 23
RetractedPLGA nanomedical consignation: A novel approach for the management of prostate cancer
Dongsar, T. S., Dongsar, T. T., Gupta, G., Alsayari, A., Wahab, S., & Kesharwani, P. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.123808 · Cited by 14
Self-citationSynthesis and anti-cancer investigations of copper(II) complexes based on adenine
Zhai, X., Hanibah, H., Hashim, N. Z. N., Zhang, J., Ma, X., Wei, L., & Zhou, X. (2024) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2024.138836 · Cited by 12
Jahanafrooz, Z., Oroojalian, F., Mokhtarzadeh, A., Rahdar, A., & Diez-Pascual, A. M. (2024) · Drug Development Research · doi:10.1002/ddr.22244 · Cited by 12
Self-citationScouting the efficacy of targeted gold nanoparticles in the landscape of cancer therapy
Fatima, M., Gupta, G., Arora, S., Alsayari, A., Wahab, S., & Kesharwani, P. (2024) · European Polymer Journal · doi:10.1016/j.eurpolymj.2024.112924 · Cited by 11
Self-citationBioresponsive Polymeric Nanoparticles: From Design, Targeted Therapy to Cancer Immunotherapy
Sun, H., & Zhong, Z. (2024) · Biomacromolecules · doi:10.1021/acs.biomac.4c01257 · Cited by 10
Wang, J., Guo, B., Sun, Z., Zhao, S., Cao, L., Zhong, Z., & Meng, F. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202400784 · Cited by 10
Zarei, Z., Azarnivand, H., Moazeni, M., Bahmani, M., Razmjoue, D., & Oroojalian, F. (2025) · Scientific Reports · doi:10.1038/s41598-025-18448-2 · Cited by 9
Self-citationAli, M. S., Alsayari, A., Wahab, S., Gupta, G., Goh, K. W., & Kesharwani, P. (2025) · Microchemical Journal · doi:10.1016/j.microc.2025.114628 · Cited by 8
Self-citationRadionuclide-labeled nanomaterials for tumor therapy: Recent progress and perspectives
Zhen, Z., Feng, L., Liu, H., Chen, M., Chen, J., & Wang, J. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102156 · Cited by 8
Responsive biomaterials for therapeutic strategies of hepatocellular carcinoma
Liao, X., Zhou, J., Feng, L., Wang, L., Wu, H., Li, J., Jia, Y., Wu, Q., & Shen, S. Y. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1673134 · Cited by 8
Wang, X., Zhao, X., Qi, H., Yuan, C., Qu, R., Lin, W., & Li, M. (2024) · ACS Applied Nano Materials · doi:10.1021/acsanm.4c05370 · Cited by 7
State-of-the-art review on liposomes as versatile cancer vaccine delivery systems
Vatankhah, A., Oroojalian, F., Moghaddam, S. H., Kesharwani, P., & Sahebkar, A. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.106975 · Cited by 7
Self-citationPolymeric Nanoarchitectures: Advanced Cargo Systems for Biological Applications
Luo, Y., Li, Y., Abdelmohsen, L. K. E. A., Shao, J., & van Hest, J. C. M. (2025) · Macromolecular Bioscience · doi:10.1002/mabi.202400540 · Cited by 4
Rahimi, M., Azizi, M., Soorgi, H., Gheybi, F., Nokhodchi, A., Amani, A., & Oroojalian, F. (2025) · BioNanoScience · doi:10.1007/s12668-025-01896-5 · Cited by 4
Self-citationWang, X., Xing, X., Dong, M., Liu, H., Zhou, Z., Zheng, J., & Dong, H. (2025) · ACS Materials Letters · doi:10.1021/acsmaterialslett.5c00050 · Cited by 4
Sialic acid-functionalized nanomaterials for targeted cancer therapy, diagnosis, and theranostics
Vatankhah, A., Moghaddam, S. H., Oroojalian, F., Kesharwani, P., & Sahebkar, A. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125901 · Cited by 3
Self-citationLiposome-mediated anticancer drug delivery strategies for advancing brain tumor therapy
Rahmanian, M., Oroojalian, F., Kesharwani, P., & Sahebkar, A. (2025) · European Polymer Journal · doi:10.1016/j.eurpolymj.2025.114001 · Cited by 4
Self-citationApplication of quantum dots for the delivery of curcumin
Khosropanah, S., Rahmanian, M., Moghaddam, S. H., Vatankhah, A., Kesharwani, P., Oroojalian, F., & Sahebkar, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-24064-5.00011-1 · Cited by 2
Self-citationThe simultaneous use of nanovesicles and magnetic nanoparticles for cancer targeting and imaging
Salatin, S., Azarfarin, M., Farjami, A., & Hamidi, S. (2024) · Therapeutic Delivery · doi:10.1080/20415990.2024.2426447 · Cited by 2
Ghazanfary, S., Rahmanian, M., Vatanchian, M., Haghbin, A., Shakeri, F., & Oroojalian, F. (2024) · BioNanoScience · doi:10.1007/s12668-024-01677-6 · Cited by 2
Self-citationNano-phytoconstituents: Recent advances, regulatory insights, challenges, and future horizons
Beygi, M. H. M., Oroojalian, F., Karav, S., Kesharwani, P., & Sahebkar, A. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.106908 · Cited by 2
Self-citationHosseini, S., Zak, A. K., Nikravesh, A., & Oroojalian, F. (2025) · Nanomedicine · doi:10.1080/17435889.2025.2582462 · Cited by 1
Self-citationPolymersomes: A Novel Approach for Cancer Theranostics
Yadav, S. C., Patel, A., Ahlawat, P., Panjwani, D., & Patel, S. (2024) · Current Nanomedicine · doi:10.2174/0124681873304030240417070617
Bhattacharya, S. (2025) · Journal of Macromolecular Science Part B · doi:10.1080/00222348.2024.2448097
Plasmonic Gold Nanorattles for Cancer Theranostics
Singh, K., Mukherjee, N., & Jaiswal, A. K. (2025) · Advanced Therapeutics · doi:10.1002/adtp.202500431
Amiryaghoubi, N., Azizollahi, F., Behnam, B., Mokhtarzadeh, A. A., & Oroojalian, F. (2026) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-026-10781-x
Self-citationOvercoming hurdles in nano-phytochemical development: challenges and future directions.
Bazi, A., Oroojalian, F., Kesharwani, P., & Sahebkar, A. (2026) · Journal of Biomaterials Science. Polymer Edition · doi:10.1080/09205063.2026.2736163
Self-citation
Metadata
- Authors
- Beygi, M., Oroojalian, F., Hosseini, S. S., Mokhtarzadeh, A., Kesharwani, P., & Sahebkar, A.
- Affiliations
- Isfahan University of Technology (IR)
- North Khorasan University of Medical Sciences (IR)
- Tabriz University of Medical Sciences (IR)
- Jamia Hamdard (IN)
- Mashhad University of Medical Sciences (IR)
- Corresponding author
- Oroojalian, Fatemeh
- Mokhtarzadeh, Ahad
- Kesharwani, Prashant
- Sahebkar, Amirhossein
- ORCID
- Venue
- Progress in Materials Science
- Publisher
- Elsevier BV
- Published
- 2023-12
- Volume
- 140
- Pages
- 101209
- ISSN
- 0079-6425 (ISSN-L)
- OpenAlex
- W4388284514
- Cited by
- 32
- References
- 375
- Citations by year
- 2026: 2 · 2025: 16 · 2024: 14
- FWCI
- 2.05
- Type
- journal article
- Language
- en
- Status
- Retracted
- Update notices
- retraction (2023-12-01)
- Open access
- closed
- Licence
- Locations
- Progress in Materials Science (publishedVersion)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Keywords
- polymersomes, nanotheranostics, cancer therapy, targeted drug delivery, biodegradable polymers, sustained drug release, personalized medicine, theranostic nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
